Skip to Main Content
March 30, 2020

Health Law Daily

FDA Issues EUA For Hydroxychloroquine, Chloroquine For Coronavirus Treatment

  • March 30, 2020

Politico (3/29, Diamond) reports that on Sunday, the FDA “issued an emergency use authorization [EUA] for hydroxychloroquine and chloroquine, decades-old malaria drugs championed by President Donald Trump for coronavirus treatment despite scant evidence.” The FDA “allowed for the drugs to be ‘donated to the Strategic National Stockpile to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible,’ HHS said in a statement, announcing that Sandoz donated 30 million doses of hydroxychloroquine to the stockpile and Bayer donated 1 million doses of chloroquine.”